Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Catatonia After Neuroleptic Malignant Syndrome Successfully Treated With Electroconvulsive Therapy.

Che J, Muralidhara S, Egbert M, Sharma A.

Prim Care Companion CNS Disord. 2019 Aug 15;21(4). pii: 18l02376. doi: 10.4088/PCC.18l02376.

2.

Quantum dot encapsulated nanocolloidal bioconjugates function as bioprobes for in vitro intracellular imaging.

Muralidhara S, Malu K, Gaines P, Budhlall BM.

Colloids Surf B Biointerfaces. 2019 Oct 1;182:110348. doi: 10.1016/j.colsurfb.2019.110348. Epub 2019 Jul 8.

PMID:
31301579
3.

Plasma Protein and Lipoprotein Binding of Cis- and Trans-Permethrin and Deltamethrin in Adult Humans and Rats.

Sethi P, Bruckner JV, Mortuza TB, Cummings BS, Muralidhara S, White CA.

Drug Metab Dispos. 2019 Sep;47(9):941-948. doi: 10.1124/dmd.118.085464. Epub 2019 Jun 27.

PMID:
31248885
4.

Effect of dose and exposure protocol on the toxicokinetics and first-pass elimination of trichloroethylene and 1,1,1-trichloroethane.

Mortuza T, Muralidhara S, White CA, Cummings BS, Hines C, Bruckner JV.

Toxicol Appl Pharmacol. 2018 Dec 1;360:185-192. doi: 10.1016/j.taap.2018.09.043. Epub 2018 Oct 1.

PMID:
30287391
5.

#Healthy Selfies: Exploration of Health Topics on Instagram.

Muralidhara S, Paul MJ.

JMIR Public Health Surveill. 2018 Jun 29;4(2):e10150. doi: 10.2196/10150.

6.

Toxicokinetics of Deltamethrin: Dosage Dependency, Vehicle Effects, and Low-Dose Age-Equivalent Dosimetry in Rats.

Mortuza T, Chen C, White CA, Cummings BS, Muralidhara S, Gullick D, Bruckner JV.

Toxicol Sci. 2018 Mar 1;162(1):327-336. doi: 10.1093/toxsci/kfx260.

PMID:
29165640
7.

Brain uptake of deltamethrin in rats as a function of plasma protein binding and blood-brain barrier maturation.

Amaraneni M, Pang J, Mortuza TB, Muralidhara S, Cummings BS, White CA, Vorhees CV, Zastre J, Bruckner JV.

Neurotoxicology. 2017 Sep;62:24-29. doi: 10.1016/j.neuro.2017.04.009. Epub 2017 May 8.

PMID:
28495520
8.

Influence of Maturation on In Vivo Tissue to Plasma Partition Coefficients for Cis- and Trans-Permethrin.

Amaraneni M, Pang J, Bruckner JV, Muralidhara S, Mortuza TB, Gullick D, Hooshfar S, White CA, Cummings BS.

J Pharm Sci. 2017 Aug;106(8):2144-2151. doi: 10.1016/j.xphs.2017.04.024. Epub 2017 Apr 23.

PMID:
28445697
9.

The immature rat as a potential model for chemical risks to children: Ontogeny of selected hepatic P450s.

McPhail BT, White CA, Cummings BS, Muralidhara S, Wilson JT, Bruckner JV.

Chem Biol Interact. 2016 Aug 25;256:167-77. doi: 10.1016/j.cbi.2016.07.005. Epub 2016 Jul 5.

PMID:
27387539
10.

Plasma protein binding limits the blood brain barrier permeation of the pyrethroid insecticide, deltamethrin.

Amaraneni M, Sharma A, Pang J, Muralidhara S, Cummings BS, White CA, Bruckner JV, Zastre J.

Toxicol Lett. 2016 May 27;250-251:21-8. doi: 10.1016/j.toxlet.2016.03.006. Epub 2016 Mar 22.

PMID:
27016408
11.

Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.

Sethi PK, White CA, Cummings BS, Hines RN, Muralidhara S, Bruckner JV.

Pediatr Res. 2016 Mar;79(3):409-15. doi: 10.1038/pr.2015.237. Epub 2015 Nov 16.

PMID:
26571224
12.

Measurement of plasma protein and lipoprotein binding of pyrethroids.

Sethi PK, Muralidhara S, Bruckner JV, White CA.

J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):106-11. doi: 10.1016/j.vascn.2014.06.002. Epub 2014 Jun 11.

PMID:
24929057
13.

Association of brominated proteins and changes in protein expression in the rat kidney with subcarcinogenic to carcinogenic doses of bromate.

Kolisetty N, Bull RJ, Muralidhara S, Costyn LJ, Delker DA, Guo Z, Cotruvo JA, Fisher JW, Cummings BS.

Toxicol Appl Pharmacol. 2013 Oct 15;272(2):391-8. doi: 10.1016/j.taap.2013.06.018. Epub 2013 Jun 26.

PMID:
23811332
14.

Changes in mRNA and protein expression in the renal cortex of male and female F344 rats treated with bromate.

Kolisetty N, Delker DA, Muralidhara S, Bull RJ, Cotruvo JA, Fisher JW, Cummings BS.

Arch Toxicol. 2013 Nov;87(11):1911-1925. doi: 10.1007/s00204-013-1052-2. Epub 2013 Apr 16.

PMID:
23588252
15.

Absorption and disposition of bromate in F344 rats.

Bull RJ, Kolisetty N, Zhang X, Muralidhara S, Quiñones O, Lim KY, Guo Z, Cotruvo JA, Fisher JW, Yang X, Delker D, Snyder SA, Cummings BS.

Toxicology. 2012 Oct 9;300(1-2):83-91. doi: 10.1016/j.tox.2012.06.002. Epub 2012 Jun 12.

PMID:
22699156
16.

Influence of exposure route and oral dosage regimen on 1, 1-dichloroethylene toxicokinetics and target organ toxicity.

Bruckner JV, White CA, Muralidhara S, Hines C, Dallas CE.

J Pharmacol Exp Ther. 2010 May;333(2):519-27. doi: 10.1124/jpet.109.162479. Epub 2010 Feb 3.

PMID:
20130112
17.

Presystemic elimination of trichloroethylene in rats following environmentally relevant oral exposures.

Liu Y, Bartlett MG, White CA, Muralidhara S, Bruckner JV.

Drug Metab Dispos. 2009 Oct;37(10):1994-8. doi: 10.1124/dmd.109.028100. Epub 2009 Jul 6.

PMID:
19581386
18.

Determination of trichloroethylene from adipose tissue by headspace solid-phase microextraction gas chromatography/mass spectrometry.

Liu Y, Muralidhara S, Bruckner JV, Bartlett MG.

Rapid Commun Mass Spectrom. 2009 Feb;23(3):455-8. doi: 10.1002/rcm.3891. No abstract available.

PMID:
19127549
19.
20.
21.

Trace level determination of trichloroethylene in biological samples by headspace solid-phase microextraction gas chromatography/negative chemical ionization mass spectrometry.

Liu Y, Muralidhara S, Bruckner JV, Bartlett MG.

Rapid Commun Mass Spectrom. 2008;22(6):797-806. doi: 10.1002/rcm.3426.

PMID:
18278820
22.

Determination of trichloroethylene in biological samples by headspace solid-phase microextraction gas chromatography/mass spectrometry.

Liu Y, Muralidhara S, Bruckner JV, Bartlett MG.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 15;863(1):26-35. doi: 10.1016/j.jchromb.2007.12.010. Epub 2007 Dec 24.

PMID:
18249161
23.

Formulation-dependent toxicokinetics explains differences in the GI absorption, bioavailability and acute neurotoxicity of deltamethrin in rats.

Kim KB, Anand SS, Muralidhara S, Kim HJ, Bruckner JV.

Toxicology. 2007 May 20;234(3):194-202. Epub 2007 Feb 28.

PMID:
17448586
24.

Effect of PCB 126 on hepatic metabolism of thyroxine and perturbations in the hypothalamic-pituitary-thyroid axis in the rat.

Fisher JW, Campbell J, Muralidhara S, Bruckner JV, Ferguson D, Mumtaz M, Harmon B, Hedge JM, Crofton KM, Kim H, Almekinder TL.

Toxicol Sci. 2006 Mar;90(1):87-95. Epub 2005 Dec 9.

PMID:
16339789
25.

Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity.

Anand SS, Kim KB, Padilla S, Muralidhara S, Kim HJ, Fisher JW, Bruckner JV.

Drug Metab Dispos. 2006 Mar;34(3):389-97. Epub 2005 Dec 2.

PMID:
16326812
26.

Characterization of deltamethrin metabolism by rat plasma and liver microsomes.

Anand SS, Bruckner JV, Haines WT, Muralidhara S, Fisher JW, Padilla S.

Toxicol Appl Pharmacol. 2006 Apr 15;212(2):156-66. Epub 2005 Sep 16.

PMID:
16169030
27.

Analysis of dichloroacetic acid in rat blood and tissues by hydrophilic interaction liquid chromatography with tandem mass spectrometry.

Delinsky AD, Delinsky DC, Muralidhara S, Fisher JW, Bruckner JV, Bartlett MG.

Rapid Commun Mass Spectrom. 2005;19(8):1075-83.

PMID:
15776496
28.

Determination of deltamethrin and its metabolite 3-phenoxybenzoic acid in male rat plasma by high-performance liquid chromatography.

Ding Y, White CA, Muralidhara S, Bruckner JV, Bartlett MG.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 25;810(2):221-7.

PMID:
15380718
29.

Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.

Keys DA, Bruckner JV, Muralidhara S, Fisher JW.

Toxicol Sci. 2003 Nov;76(1):35-50. Epub 2003 Aug 12.

PMID:
12915716
30.

Trace level determination of trichloroethylene from liver, lung and kidney tissues by gas chromatography-magnetic sector mass spectrometry.

Brown SD, Muralidhara S, Bruckner JV, Bartlett MG.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 15;783(2):319-25.

PMID:
12482474
31.

Mechanisms of circadian rhythmicity of carbon tetrachloride hepatotoxicity.

Bruckner JV, Ramanathan R, Lee KM, Muralidhara S.

J Pharmacol Exp Ther. 2002 Jan;300(1):273-81.

PMID:
11752126
32.

Acute, subacute, and subchronic oral toxicity studies of 1,1-dichloroethane in rats: application to risk evaluation.

Muralidhara S, Ramanathan R, Mehta SM, Lash LH, Acosta D, Bruckner JV.

Toxicol Sci. 2001 Nov;64(1):135-45.

PMID:
11606809
33.

Acute, short-term, and subchronic oral toxicity of 1,1,1-trichloroethane in rats.

Bruckner JV, Kyle GM, Luthra R, Acosta D, Mehta SM, Sethuraman S, Muralidhara S.

Toxicol Sci. 2001 Apr;60(2):363-72.

PMID:
11248149
34.

Mechanisms of the dose-dependent kinetics of trichloroethylene: oral bolus dosing of rats.

Lee KM, Muralidhara S, White CA, Bruckner JV.

Toxicol Appl Pharmacol. 2000 Apr 1;164(1):55-64.

PMID:
10739744
35.

Contribution of direct solvent injury to the dose-dependent kinetics of trichloroethylene: portal vein administration to rats.

Lee KM, Muralidhara S, Schnellmann RG, Bruckner JV.

Toxicol Appl Pharmacol. 2000 Apr 1;164(1):46-54.

PMID:
10739743
36.

Simple method for rapid measurement of trichloroethylene and its major metabolites in biological samples.

Muralidhara S, Bruckner JV.

J Chromatogr B Biomed Sci Appl. 1999 Sep 10;732(1):145-53.

PMID:
10517231
37.

Effects of acute inhalation exposure to isoamyl nitrite on the hypothalamo-pituitary-adrenal axis in male Sprague-Dawley rats.

Ramanathan VM, Reigle TG, Muralidhara S, Dallas CE.

J Toxicol Environ Health A. 1998 Nov 13;55(5):345-58.

PMID:
9829558
38.

Effects of acute inhalation exposure to 1,1,1-trichloroethane on the hypothalamo-pituitary-adrenal axis in male Sprague-Dawley rats.

Pise VM, Reigle TG, Muralidhara S, Dallas CE.

J Toxicol Environ Health A. 1998 Jun 12;54(3):193-208.

PMID:
9643872
39.

Schedule-controlled operant behavior of rats during 1,1,1-trichloroethane inhalation: relationship to blood and brain solvent concentrations.

Warren DA, Reigle TG, Muralidhara S, Dallas CE.

Neurotoxicol Teratol. 1998 Mar-Apr;20(2):143-53.

PMID:
9536460
40.

Uptake, distribution, and elimination of carbon tetrachloride in rat tissues following inhalation and ingestion exposures.

Sanzgiri UY, Srivatsan V, Muralidhara S, Dallas CE, Bruckner JV.

Toxicol Appl Pharmacol. 1997 Mar;143(1):120-9.

PMID:
9073600
41.

Lack of volatilization and escape of orally administered trichloroethylene from the gastrointestinal tract of rats.

Lee KM, Muralidhara S, Dallas CE, Bruckner JV.

Toxicol Ind Health. 1997 Jan-Feb;13(1):81-9.

PMID:
9098953
42.

Characterization of presystemic elimination of trichloroethylene and its nonlinear kinetics in rats.

Lee KM, Bruckner JV, Muralidhara S, Gallo JM.

Toxicol Appl Pharmacol. 1996 Aug;139(2):262-71.

PMID:
8806842
43.
44.

Effect of route and pattern of exposure on the pharmacokinetics and acute hepatotoxicity of carbon tetrachloride.

Sanzgiri UY, Kim HJ, Muralidhara S, Dallas CE, Bruckner JV.

Toxicol Appl Pharmacol. 1995 Sep;134(1):148-54.

PMID:
7676449
45.

Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.

Dallas CE, Chen XM, Muralidhara S, Varkonyi P, Tackett RL, Bruckner JV.

J Toxicol Environ Health. 1995 Mar;44(3):301-17.

PMID:
7897693
46.

Comparisons between operant response and 1,1,1-trichloroethane toxicokinetics in mouse blood and brain.

You L, Muralidhara S, Dallas CE.

Toxicology. 1994 Nov 11;93(2-3):151-63.

PMID:
7974511
47.

The pharmacokinetics of inhaled 1,1,1-trichloroethane following high milk intake in mice.

You L, Dallas CE, Muralidhara S.

Drug Chem Toxicol. 1994 Nov;17(4):479-98.

PMID:
7821234
48.

Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.

Dallas CE, Chen XM, Muralidhara S, Varkonyi P, Tackett RL, Bruckner JV.

Environ Res. 1994 Oct;67(1):54-67.

PMID:
7925194
49.

Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.

Dallas CE, Muralidhara S, Chen XM, Ramanathan R, Varkonyi P, Gallo JM, Bruckner JV.

Toxicol Appl Pharmacol. 1994 Sep;128(1):60-8.

PMID:
8079355
50.

Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data.

Dallas CE, Chen XM, O'Barr K, Muralidhara S, Varkonyi P, Bruckner JV.

Toxicol Appl Pharmacol. 1994 Sep;128(1):50-9.

PMID:
8079354

Supplemental Content

Loading ...
Support Center